Linden develops relationships with the world’s leading healthcare and life science companies.
Linden’s sourcing strategy is aimed at creating proprietary or advantaged investment opportunities. To accomplish this objective, Linden uses three interlocking resources:
Corporate relationship management program
In-house market intelligence program
Relationships with industry executives
These efforts augment Linden’s traditional sourcing through investment banks, business brokers, attorneys and accountants.
A key component of Linden’s strategy is building long-term relationships with the largest healthcare and life science companies in the world. Linden’s in-house market intelligence program drives the initial identification of targets and enables the direct dialogue with corporations. Linden's executive network provides personal introductions to the corporations. To date, Linden has developed over 70 such relationships with large healthcare and life science corporations and has multiple contacts at various levels within each company.
Through this corporate relationship management program, Linden proactively meets with senior executives to:
Create strategic alternatives for a parent corporation’s non-core operations while creating proprietary investment opportunities for Linden
Offer leads to independent businesses the corporate executives may know
Provide strategic advice and perspective that is useful to corporations and their non-core operations
Create flexible and innovative transaction structures that enable corporations to harvest more value from their maturing operations. Often, this takes the form of a continued minority ownership stake in the business.
